È $27 million in new kidney transplant and dialysis facilities, part of the consolidation of a handful of medical programs with Kaleida Health.

... http://www.buffalonews.com/incoming/article262442.ece

Commenting on the findings, which were presented at the annual American Society of Nephrology meeting this week, lead study investigator Donald Kohan, ...

Reata Pharmaceuticals and Abbott present encouraging clinical data at American ... Trading Markets (press release)

Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan

... http://www.pharmatimes.com/Article/10-11-23/Abbott_s_atrasentan_shines_in_diabetic_kidney_disease_trial.aspx